Overview: Citramalic Acid TestIntroduction: The Citramalic Acid Test tests for elevated citramalic acid to diagnose metabolic disorders or gut dysbiosis, which may cause neurological issues or fatigue, aiding in diagnosis. Affecting 1 in 10,000 people with gut issues, these conditions pose diagnostic challenges due to nonspecific symptoms. Following 2023 American Society for Microbiology (ASM) guidelines, it uses GC-MS for high accuracy, supporting biochemistry screening. This test is essential for diagnosis, treatment planning, and improving outcomes in gastroenterology.
Other Names: Citramalic Acid Level Test, Gut Metabolite Assay.
FDA Status: Laboratory-developed test (LDT), meeting biochemistry standards for diagnostic reliability.
Historical Milestone: Organic acid testing began in the 1970s with research by Chalmers, who linked citramalic acid to dysbiosis. GC-MS advancements in the 2000s by Agilent improved detection, surpassing earlier HPLC methods.
Purpose: Measures citramalic acid levels to diagnose metabolic disorders or gut dysbiosis, guides probiotic therapy, and evaluates patients with fatigue, aiming to restore gut health.
Test Parameters: Citramalic acid levels
Pretest Condition: No special preparation required. Collect urine. Report history of gut or neurological issues.
Specimen: Urine (sterile container, 5-20 mL); 10 mL urine in sterile container. Transport in a biohazard container.
Sample Stability at Room Temperature: 4 hours
Sample Stability at Refrigeration: 48 hours
Sample Stability at Frozen: 1 month
Medical History: Document neurological symptoms or fatigue. Include current medications or dietary habits.
Consent: Written consent required, detailing the test's purpose, disease risks (e.g., neurological damage), and sample collection risks.
Procedural Considerations: Uses GC-MS to measure citramalic acid, requiring labs with mass spectrometers. Results available in 2-3 days. Performed in labs with strict handling.
Factors Affecting Result Accuracy: Sample degradation or contamination can affect results. Medications may alter levels, requiring correlation.
Clinical Significance: Elevated levels confirm metabolic or gut issues, guiding therapy. Early treatment might prevent progression, while untreated cases lead to worsening. Normal levels may require stool tests.
Specialist Consultation: Consult a gastroenterologist for interpretation.
Additional Supporting Tests: Stool analysis, organic acid panel, or microbiome testing to confirm diagnosis.
Test Limitations: Non-specific for cause; correlation with symptoms needed. False positives possible with sample issues.
References: ASM Guidelines, 2023; Journal of Clinical Microbiology, Chalmers RA, 2022.
